Drugs for HER-2-positive Breast Cancer: Milestones in Drug Therapy
Editat de Maria Sibilia, Christoph C. Zielinski, Rupert Bartsch, Thomas W. Grunten Limba Engleză Paperback – 25 feb 2013
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1043.64 lei 6-8 săpt. | |
Springer – 25 feb 2013 | 1043.64 lei 6-8 săpt. | |
Hardback (1) | 1048.20 lei 6-8 săpt. | |
Springer – 7 ian 2011 | 1048.20 lei 6-8 săpt. |
Din seria Milestones in Drug Therapy
- 5% Preț: 1356.22 lei
- 5% Preț: 840.04 lei
- 5% Preț: 357.86 lei
- 5% Preț: 351.74 lei
- 5% Preț: 684.62 lei
- 5% Preț: 694.47 lei
- 5% Preț: 624.61 lei
- 5% Preț: 1061.24 lei
- 5% Preț: 1353.93 lei
- 5% Preț: 350.84 lei
- 5% Preț: 667.35 lei
- 5% Preț: 1052.08 lei
- 5% Preț: 347.51 lei
- 5% Preț: 681.80 lei
- 5% Preț: 351.39 lei
- 5% Preț: 1057.70 lei
- 5% Preț: 1055.61 lei
- 5% Preț: 1235.40 lei
- 5% Preț: 617.23 lei
- 5% Preț: 1058.94 lei
- 5% Preț: 1545.84 lei
- 5% Preț: 1371.69 lei
- 5% Preț: 671.69 lei
- 5% Preț: 683.38 lei
- 5% Preț: 1733.17 lei
- 5% Preț: 1058.59 lei
- 5% Preț: 1362.92 lei
- 5% Preț: 1051.19 lei
- 5% Preț: 689.56 lei
- 5% Preț: 691.65 lei
- 5% Preț: 688.32 lei
- 5% Preț: 1050.84 lei
- 5% Preț: 1051.59 lei
- 5% Preț: 1061.58 lei
- 5% Preț: 1237.14 lei
Preț: 1043.64 lei
Preț vechi: 1098.56 lei
-5% Nou
Puncte Express: 1565
Preț estimativ în valută:
199.74€ • 210.72$ • 166.45£
199.74€ • 210.72$ • 166.45£
Carte tipărită la comandă
Livrare economică 02-16 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783034803182
ISBN-10: 3034803184
Pagini: 120
Ilustrații: X, 110 p.
Dimensiuni: 155 x 235 x 6 mm
Greutate: 0.18 kg
Ediția:2011
Editura: Springer
Colecția Springer
Seria Milestones in Drug Therapy
Locul publicării:Basel, Switzerland
ISBN-10: 3034803184
Pagini: 120
Ilustrații: X, 110 p.
Dimensiuni: 155 x 235 x 6 mm
Greutate: 0.18 kg
Ediția:2011
Editura: Springer
Colecția Springer
Seria Milestones in Drug Therapy
Locul publicării:Basel, Switzerland
Public țintă
ResearchCuprins
Drugs for HER-2-positive Breast Cancer: A Major Approval for Translational Cancer Research (Maria Sibilia, Christoph C. Zielinski, Rupert Bartsch, Thomas Grunt).- The EGFR/ErbB family in breast cancer: from signaling to therapy (Wolfgang J. Köstler and Yosef Yarden).- Trastuzumab as Adjuvant treatment for early stage HER-2 positive breast cancer (Rupert Bartsch and Guenther G. Steger).- Trastuzumab Resistance in breast cancer (Floriana Morgillo, Michele Orditura, Teresa Troiani, Erika Martinelli, Ferdinando De Vita, Fortunato Ciardiello).- Treatment with Trastuzumab beyond Progression (Gunter von Minckwitz and Cristina Pirvulescu).- Pertuzumab – a HER-2 dimerisation inhibitor – for the treatment of breast and other cancers (Giulia Bianchi and Luca Gianni).- Beyond trastuzumab: Second generation targeted therapies for HER2--positive breast cancer (Flavio F. Solca, Guenther R. Adolf, Hilary Jones, Martina M. Uttenreuther-Fischer).
Recenzii
From the reviews:
“This book takes readers on a journey from HER-2 signalling to therapeutic use of trastuzumab in the neoadjuvant, adjuvant and metastatic settings. … It is a tour-de-force and should be essential reading for anyone setting out in the HER-2 research field. … Overall, this small book covers the topic of HER-2 inhibition very well in a field that is rapidly changing.” (S. W. Wong and R. M. Lowenthal, Inflammation Research, Vol. 61, 2012)
“This book takes readers on a journey from HER-2 signalling to therapeutic use of trastuzumab in the neoadjuvant, adjuvant and metastatic settings. … It is a tour-de-force and should be essential reading for anyone setting out in the HER-2 research field. … Overall, this small book covers the topic of HER-2 inhibition very well in a field that is rapidly changing.” (S. W. Wong and R. M. Lowenthal, Inflammation Research, Vol. 61, 2012)
Caracteristici
Contemporary monograph on the treatment of breast cancer.- Gives a comprehensive account of drugs for HER2-positive breast cancer.- A valuable source of information for researchers and clinicians from the fields of oncology and pharmacology Includes supplementary material: sn.pub/extras